[How many and who are receiving medication for XXXX ?].

@entity1 @entity6
BACKGROUND: This study presents data on the prevalence and incidence of @entity6 in Norway based on the new Norwegian Prescription Database (NorPD). MATERIAL AND METHODS: We used data from the NorPD (2004-June 2005) and the official wholesales statistics (2000-2004). The number of @entity1 with at least one prescription for drugs used in @entity6 was recorded, together with gender and age distribution among the users. RESULTS: The one-year prevalence in 2004 of drug-treated @entity6 was 2.6% for @entity1 and 2.2% for @entity1 . 9% of @entity1 in the 70-79 year age-group received antidiabetic drugs. 46 000 @entity1 were recorded with at least one prescription on insulin, while 79,000 @entity1 collected at least one prescription on tablets. The one-year prevalence of insulin users in the age-group younger than 15 years was estimated to 2.0 per 1000. The incidence rate, calculated from data from the first half of 2005, was 35 per 100,000 @entity1 -years. INTERPRETATION: The NorPD represents a new data source which offers good estimates for the number of @entity1 diagnosed with @entity6 who receive antidiabetic drugs outside hospitals or nursing homes. The 2004 prevalence was in accordance with previous surveys, while the incidence rate of type 1 @entity6 in @entity1 younger than 15 years was higher than previously shown.
